Sun Pharmaceutical Industries Ltd - Financial Result for the Quarter ended 30th Sep'26
Sun Pharmaceutical Industries Ltd · Financial Result · 30 Oct 2026, 7:44 pm
Sun Pharmaceutical Industries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 1,61,987 (+11.9% YoY | +5.9% QoQ) ■ EBITDA: 47,439 (+4.8% YoY | +7.4% QoQ) ■ EBITDA Margin (%): 29.3 (-198 bps YoY | +41 bps QoQ) ■ PAT: 19,885 (-36.2% YoY | -31.3% QoQ) ■ EPS (INR): 8.30 (-36.2% YoY | -31.4% QoQ)
Original exchange filing (PDF)
More announcements from Sun Pharmaceutical Industries Ltd
- Intimation of Schedule of Analyst/Institutional Investor Meeting · 05 Nov 2026
- Q2FY27 Earnings Call Transcript · 05 Nov 2026
- Clarification regarding news report relating to the Company''s Assam facility · 03 Nov 2026
- The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting .... · 02 Nov 2026
- Completion and results of postal ballot dated 01 October 2026 · 01 Nov 2026
- Q2FY27- Investor Call Audio Recording · 31 Oct 2026
- Board Meeting Outcome - Conclusion · 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 · 30 Oct 2026
